Faculty

Back to Index
Robert Alan Kloner, MD, PhD
Professor of Medicine (Clinical Scholar)
Medicine
IRD 620 Off Campus Los Angeles
+1 626 397 5811

Awards

Consumer's Research Council of America: Listed in Guide to America's Top Cardiologists, 2007

Good Samaritan Hospital : Physician Leadership Award, 2003

Institute for Scientific Information: Identified as one of the world's most highly cited authors, 2002

American Heart Association: Inaugural Fellow of the Council on Basic Cardiovascular Sciences, 2001

United States Israel Binational Science Foundation: The Henry N. Neufeld Memorial Award, 1996

NIH: Cardiovascular Study Section A, 1995-1998

American Heart Association : Continuing Service Award, 1991

American Society for Clinical Investigation: Elected Member, 1990

American College of Physicians: Research Prize, 1988

82nd Annual Scientific Assembly of the Southern Medical Association: Scientific Exhibit Achievement Award, 1988

American Heart Association: Recipient of the Established Investigatorship Award, 1981-1986

American Society of Clinical Pathologists: Sheard-Sanford Award for Meritorius Original Student Research in Pathology During Medical School, 1976

Merck: Award for Outstanding Achievement in the Study of Medicine, 1975

Alpha Omega Alpha: Member, 1973

Publications

Therapeutic Hypothermia Reduces the Inflammatory Response Following Ischemia/Reperfusion Injury in Rat Hearts. Ther Hypothermia Temp Manag. 2017 Sep; 7(3):162-170. View in: PubMed

Mitochondrial Protective Agents for Ischemia/Reperfusion Injury. Circ Cardiovasc Interv. 2017 Sep; 10(9). View in: PubMed

New and revisited approaches to preserving the reperfused myocardium. Nat Rev Cardiol. 2017 Jul 27. View in: PubMed

The Cardiovascular Effects of Cocaine. J Am Coll Cardiol. 2017 Jul 04; 70(1):101-113. View in: PubMed

Noninvasive iPhone Measurement of Left Ventricular Ejection Fraction Using Intrinsic Frequency Methodology. Crit Care Med. 2017 Jul; 45(7):1115-1120. View in: PubMed

Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model. Int J Cardiol. 2017 Jun 01; 236:400-404. View in: PubMed

Angina and Its Management. J Cardiovasc Pharmacol Ther. 2017 May; 22(3):199-209. View in: PubMed

Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations. Eur Heart J. 2017 Apr 01; 38(13):935-941. View in: PubMed

Heart Failure-Induced Brain Injury. J Am Coll Cardiol. 2017 Mar 28; 69(12):1609-1616. View in: PubMed

Therapeutic Hypothermia Reduces the Inflammatory Response Following Ischemia/Reperfusion Injury in Rat Hearts. Ther Hypothermia Temp Manag. 2017 Mar 24. View in: PubMed

Management of No-Reflow Phenomenon in the Catheterization Laboratory. JACC Cardiovasc Interv. 2017 Feb 13; 10(3):215-223. View in: PubMed

Cardioprotection: Where to from here? Cardiovasc Drugs Ther. Cardioprotection: Where to from here? Cardiovasc Drugs Ther. 2017 Feb; 31(1):53-61. View in: PubMed

Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model. Int J Cardiol. 2017 Jan 12. View in: PubMed

Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion. Cardiovasc Drugs Ther. 2016 Dec; 30(6):559-566. View in: PubMed

Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion. Cardiovasc Drugs Ther. 2016 Oct 17. View in: PubMed

Cardioprotection: Where to from here? Cardiovasc Drugs Ther. Cardioprotection: Where to from here? Cardiovasc Drugs Ther. 2016 Oct 6. View in: PubMed

Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial). Am J Cardiol. 2016 Sep 1; 118(5):625-31. View in: PubMed

Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial). Am J Cardiol. 2016 Sep 01; 118(5):625-31. View in: PubMed

Cardiovascular Effects of Marijuana. J Cardiovasc Pharmacol Ther. 2016 Sep; 21(5):452-5. View in: PubMed

Reply: Testosterone and Cardiac Diastolic Function. J Am Coll Cardiol. 2016 Aug 2; 68(5):574-5. View in: PubMed

Reply: Testosterone and Cardiac Diastolic Function. J Am Coll Cardiol. 2016 Aug 02; 68(5):574-5. View in: PubMed

Approaches to Improving Cardiac Structure and Function During and After an Acute Myocardial Infarction: Acute and Chronic Phases. J Cardiovasc Pharmacol Ther. 2016 Jul; 21(4):363-7. View in: PubMed

Intravenous Beta-Blockade for Limiting Myocardial Infarct Size: Rejuvenation of a Concept. J Am Coll Cardiol. 2016 May 10; 67(18):2105-7. View in: PubMed

Testosterone Replacement Therapy: New Data on Efficacy and Cardiovascular Safety. J Cardiovasc Pharmacol Ther. 2016 Apr 28. View in: PubMed

Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations. Eur Heart J. 2016 Apr 26. View in: PubMed

EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention. Eur Heart J. 2016 Apr 21; 37(16):1296-303. View in: PubMed

Remote Ischemic Conditioning: Its Benefits and Limitations. J Cardiovasc Pharmacol Ther. 2016 Mar; 21(2):219-21. View in: PubMed

Testosterone and Cardiovascular Disease. J Am Coll Cardiol. 2016 Feb 09; 67(5):545-57. View in: PubMed

Testosterone and Cardiovascular Disease. J Am Coll Cardiol. 2016 Feb 9; 67(5):545-57. View in: PubMed

Letter to the editor response. Trends Cardiovasc Med. 2016 Feb; 26(2):203. View in: PubMed

Angina and Its Management. J Cardiovasc Pharmacol Ther. 2016 Jan 01; 1074248416679733. View in: PubMed

Bendavia restores mitochondrial energy metabolism gene expression and suppresses cardiac fibrosis in the border zone of the infarcted heart. Life Sci. 2015 Nov 15; 141:170-8. View in: PubMed

Relation of Total and Cardiovascular Death Rates to Climate System, Temperature, Barometric Pressure, and Respiratory Infection. Am J Cardiol. 2015 Oct 15; 116(8):1290-7. View in: PubMed

Rebuilding the infarcted heart with noncellular material. Regen Med. 2015 Sep; 10(6):683-5. View in: PubMed

Cardiovascular consequences of cocaine use. Trends Cardiovasc Med. 2015 Aug; 25(6):517-26. View in: PubMed

Rapid Surface Cooling by ThermoSuit System Dramatically Reduces Scar Size, Prevents Post-Infarction Adverse Left Ventricular Remodeling, and Improves Cardiac Function in Rats. J Am Heart Assoc. 2015 Jun 26; 4(7). View in: PubMed

The safety and efficacy of peripheral vascular procedures performed in the outpatient setting. J Invasive Cardiol. 2015 May; 27(5):243-9. View in: PubMed

Rapid Induction of Hypothermia by the ThermoSuit System Profoundly Reduces Infarct Size and Anatomic Zone of No Reflow Following Ischemia-Reperfusion in Rabbit and Rat Hearts. J Cardiovasc Pharmacol Ther. 2015 Mar; 20(2):193-202. View in: PubMed

Testosterone and Cardiovascular Health: Safety of Treatment of Hypogonadism. Sex Med Rev. 2015 Mar; 3(1):56-62. View in: PubMed

New observations regarding post-ischemia/reperfusion myocardial swelling. J Am Coll Cardiol. 2015 Feb 03; 65(4):324-6. View in: PubMed

New observations regarding post-ischemia/reperfusion myocardial swelling. J Am Coll Cardiol. 2015 Feb 3; 65(4):324-6. View in: PubMed

New therapies for reducing post-myocardial left ventricular remodeling. Ann Transl Med. 2015 Feb; 3(2):20. View in: PubMed

Rapid Surface Cooling by ThermoSuit System Dramatically Reduces Scar Size, Prevents Post-Infarction Adverse Left Ventricular Remodeling, and Improves Cardiac Function in Rats. J Am Heart Assoc. 2015; 4(7). View in: PubMed

Does sex influence the incidence or severity of reperfusion-induced cardiac arrhythmias? Springerplus. Does sex influence the incidence or severity of reperfusion-induced cardiac arrhythmias? Springerplus. 2015; 4:96. View in: PubMed

Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusion. J Thromb Thrombolysis. 2015 Jan; 39(1):50-4. View in: PubMed

Rebuilding the infarcted heart with noncellular material. Regen Med. 2015; 10(6):683-5. View in: PubMed

Bendavia, a mitochondria-targeting peptide, improves postinfarction cardiac function, prevents adverse left ventricular remodeling, and restores mitochondria-related gene expression in rats. J Cardiovasc Pharmacol. 2014 Dec; 64(6):543-53. View in: PubMed

Hypothermia in the setting of experimental acute myocardial infarction: a comprehensive review. Ther Hypothermia Temp Manag. 2014 Dec; 4(4):159-67. View in: PubMed

Combined remote perconditioning and postconditioning failed to attenuate infarct size and contractile dysfunction in a rat model of coronary artery occlusion. J Cardiovasc Pharmacol Ther. 2014 Nov; 19(6):567-73. View in: PubMed

Ranolazine treatment for myocardial infarction? Effects on the development of necrosis, left ventricular function and arrhythmias in experimental models. Cardiovasc Drugs Ther. 2014 Oct; 28(5):469-75. View in: PubMed

Capsaicin-induced cardioprotection. Is hypothermia or the salvage kinase pathway involved? Cardiovasc Drugs Ther. 2014 Aug; 28(4):295-301. View in: PubMed

The Therapeutic Effect of Cell Transplantation Versus Noncellular Biomaterial Implantation on Cardiac Structure and Function Following Myocardial Infarction. J Cardiovasc Pharmacol Ther. 2014 Jul; 19(4):350-357. View in: PubMed

Functional and histological assessment of an experimental model of Takotsubo's cardiomyopathy. J Am Heart Assoc. 2014 Jun 23; 3(3):e000921. View in: PubMed

A systematic review of the association between erectile dysfunction and cardiovascular disease. Eur Urol. 2014 May; 65(5):968-78. View in: PubMed

Recreational marijuana use: is it safe for your patient? J Am Heart Assoc. Recreational marijuana use: is it safe for your patient? J Am Heart Assoc. 2014 Apr 23; 3(2):e000904. View in: PubMed

All men with vasculogenic erectile dysfunction require a cardiovascular workup. Am J Med. 2014 Mar; 127(3):174-82. View in: PubMed

Improved myocardial perfusion after transmyocardial laser revascularization in a patient with microvascular coronary artery disease. SAGE Open Med Case Rep. 2014; 2:2050313X14526873. View in: PubMed

Functional and Histological Assessment of an Experimental Model of Takotsubo's Cardiomyopathy. J Am Heart Assoc. 2014; 3(3). View in: PubMed

Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia. J Cardiovasc Pharmacol Ther. 2014 Jan; 19(1):121-32. View in: PubMed

Recreational Marijuana Use: Is it Safe for Your Patient? J Am Heart Assoc. Recreational Marijuana Use: Is it Safe for Your Patient? J Am Heart Assoc. 2014; 3(2):e000904. View in: PubMed

Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Am J Cardiol. 2014 Jan 1; 113(1):187-90. View in: PubMed

Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Am J Cardiol. 2014 Jan 01; 113(1):187-90. View in: PubMed

Testosterone and the cardiovascular system: a comprehensive review of the clinical literature. J Am Heart Assoc. 2013 Nov 15; 2(6):e000272. View in: PubMed

Role of protein kinase C in ischemic "conditioning": from first evidence to current perspectives. J Cardiovasc Pharmacol Ther. 2013 Nov; 18(6):525-32. View in: PubMed

Super Bowl outcome's association with cardiovascular death. Clin Res Cardiol. 2013 Nov; 102(11):807-11. View in: PubMed

Efficacy and safety of ranolazine in patients with chronic stable angina. Postgrad Med. 2013 Nov; 125(6):53-61. View in: PubMed

Efficacy and safety of ranolazine in patients with chronic stable angina. Postgrad Med. 2013 Nov; 125(6):43-52. View in: PubMed

Current state of clinical translation of cardioprotective agents for acute myocardial infarction. Circ Res. 2013 Aug 02; 113(4):451-63. View in: PubMed

Current state of clinical translation of cardioprotective agents for acute myocardial infarction. Circ Res. 2013 Aug 2; 113(4):451-63. View in: PubMed

Testosterone and the cardiovascular system: a comprehensive review of the basic science literature. J Am Heart Assoc. 2013 Aug; 2(4):e000271. View in: PubMed

Remote ischemic preconditioning for coronary artery bypass graft operations. Ann Thorac Surg. 2013 Aug; 96(2):727-36. View in: PubMed

Can myocardial infarct size be reduced by mechanically unloading the left ventricle? Circulation. Can myocardial infarct size be reduced by mechanically unloading the left ventricle? Circulation. 2013 Jul 23; 128(4):318-21. View in: PubMed

Testosterone and the cardiovascular system: a comprehensive review of the basic science literature. J Am Heart Assoc. 2013 Jul 10; 2(4):e000271. View in: PubMed

Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk. J Urol. 2013 Jun; 189(6):2031-8. View in: PubMed

Sexual function in patients with chronic angina pectoris. Am J Cardiol. 2013 Jun 01; 111(11):1671-6. View in: PubMed

Sexual function in patients with chronic angina pectoris. Am J Cardiol. 2013 Jun 1; 111(11):1671-6. View in: PubMed

Intramyocardial injection of heart tissue-derived extracellular matrix improves postinfarction cardiac function in rats. J Cardiovasc Pharmacol Ther. 2013 May; 18(3):270-9. View in: PubMed

A brief review of useful tips for publishing your scientific manuscript. J Cardiovasc Pharmacol Ther. 2013 May; 18(3):197-8. View in: PubMed

Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction. Am Heart J. 2013 Apr; 165(4):509-514. e7. View in: PubMed

Phosphodiesterase type 5 inhibitors improve endothelial function and may benefit cardiovascular conditions. Am J Med. 2013 Mar; 126(3):192-9. View in: PubMed

Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size. J Am Heart Assoc. 2013 Feb; 2(1):e004234. View in: PubMed

Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size. J Am Heart Assoc. 2013 Jan 04; 2(1):e004234. View in: PubMed

Experience from experimental cell transplantation therapy of myocardial infarction: what have we learned? Cell Transplant. Experience from experimental cell transplantation therapy of myocardial infarction: what have we learned? Cell Transplant. 2013; 22(3):563-8. View in: PubMed

The small molecule Wnt signaling modulator ICG-001 improves contractile function in chronically infarcted rat myocardium. PLoS One. 2013; 8(9):e75010. View in: PubMed

Testosterone and the cardiovascular system: a comprehensive review of the clinical literature. J Am Heart Assoc. 2013; 2(6):e000272. View in: PubMed

Continuous heliox breathing and the extent of anatomic zone of noreflow and necrosis following ischemia/reperfusion in the rabbit heart. Open Cardiovasc Med J. 2013; 8:1-5. View in: PubMed

The effect of acute versus delayed remote ischemic preconditioning on reperfusion induced ventricular arrhythmias. J Cardiovasc Electrophysiol. 2012 Dec; 23(12):1374-83. View in: PubMed

Absence of actions of commonly used Chinese herbal medicines and electroacupuncture on myocardial infarct size. J Cardiovasc Pharmacol Ther. 2012 Dec; 17(4):403-11. View in: PubMed

An apoptosis signal-regulating kinase 1 inhibitor reduces cardiomyocyte apoptosis and infarct size in a rat ischemia-reperfusion model. J Cardiovasc Pharmacol. 2012 Sep; 60(3):276-82. View in: PubMed

Therapeutic hypothermia for acute myocardial infarction and cardiac arrest. Am J Cardiol. 2012 Aug 1; 110(3):461-6. View in: PubMed

Devices to treat peripheral chronic total occlusions. J Interv Cardiol. 2012 Aug; 25(4):395-403. View in: PubMed

The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012 Aug; 87(8):766-78. View in: PubMed

Therapeutic hypothermia for acute myocardial infarction and cardiac arrest. Am J Cardiol. 2012 Aug 01; 110(3):461-6. View in: PubMed

Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes. Am Heart J. 2012 Jul; 164(1):21-8. View in: PubMed

Treating peripheral arterial disease percutaneously with atherectomy. J Invasive Cardiol. 2012 Jun; 24(6):263-9. View in: PubMed

Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide. J Am Heart Assoc. 2012 Jun; 1(3):e001644. View in: PubMed

How the 2008 stock market crash and seasons affect total and cardiac deaths in Los Angeles County. Am J Cardiol. 2012 May 15; 109(10):1445-8. View in: PubMed

Treating Refractory Cardiogenic Shock With the TandemHeart and Impella Devices: A Single Center Experience. Cardiol Res. 2012 Apr; 3(2):54-66. View in: PubMed

Coronary no reflow. J Mol Cell Cardiol. 2012 Apr; 52(4):873-82. View in: PubMed

Is inhibition of phosphodiesterase type 5 by sildenafil a promising therapy for volume-overload heart failure? Circulation. Is inhibition of phosphodiesterase type 5 by sildenafil a promising therapy for volume-overload heart failure? Circulation. 2012 Mar 20; 125(11):1341-3. View in: PubMed

An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials. J Am Coll Cardiol. 2012 Mar 13; 59(11):969-78. View in: PubMed

Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012 Feb 28; 125(8):1058-72. View in: PubMed

Cardiac uses of phosphodiesterase-5 inhibitors. J Am Coll Cardiol. 2012 Jan 03; 59(1):9-15. View in: PubMed

Cardiac uses of phosphodiesterase-5 inhibitors. J Am Coll Cardiol. 2012 Jan 3; 59(1):9-15. View in: PubMed

Genetically Engineered Mesenchymal Stem Cells Influence Gene Expression in Donor Cardiomyocytes and the Recipient Heart. J Stem Cell Res Ther. 2012; S1. View in: PubMed

Rotational Atherectomy and Stent Implantation for Calcified Left Main Lesions. Cardiol Res. 2011 Oct; 2(5):208-217. View in: PubMed

Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors. Expert Opin Pharmacother. 2011 Oct; 12(15):2297-313. View in: PubMed

High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience. J Invasive Cardiol. 2011 Oct; 23(10):417-24. View in: PubMed

New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation. 2011 Sep 6; 124(10):1172-9. View in: PubMed

New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation. 2011 Sep 06; 124(10):1172-9. View in: PubMed

No-reflow phenomenon: maintaining vascular integrity. J Cardiovasc Pharmacol Ther. 2011 Sep-Dec; 16(3-4):244-50. View in: PubMed

State of the science of cardioprotection: Challenges and opportunities--proceedings of the 2010 NHLBI Workshop on Cardioprotection. J Cardiovasc Pharmacol Ther. 2011 Sep-Dec; 16(3-4):223-32. View in: PubMed

Introduction to proceedings of the NHLBI workshop: New Horizons in cardioprotection--a focused issue of journal of cardiovascular pharmacology and therapeutics. J Cardiovasc Pharmacol Ther. 2011 Sep-Dec; 16(3-4):222. View in: PubMed

Cardioprotection of insulin-like growth factor-1 during reperfusion therapy: what is the underlying mechanism or mechanisms? Circ Cardiovasc Interv. Cardioprotection of insulin-like growth factor-1 during reperfusion therapy: what is the underlying mechanism or mechanisms? Circ Cardiovasc Interv. 2011 Aug; 4(4):311-3. View in: PubMed

The antianginal agent ranolazine is a potent antiarrhythmic agent that reduces ventricular arrhythmias: through a mechanism favoring inhibition of late sodium channel. Cardiovasc Ther. 2011 Aug; 29(4):e36-41. View in: PubMed

Protecting the heart from ischemia: an update on ischemic and pharmacologic conditioning. Hosp Pract (Minneap). 2011 Aug; 39(3):35-43. View in: PubMed

Diannexin reduces no-reflow after reperfusion in rabbits with large ischemic myocardial risk zones. Cardiovasc Ther. 2011 Aug; 29(4):e42-52. View in: PubMed

Mild hypothermia as a cardioprotective approach for acute myocardial infarction: laboratory to clinical application. J Cardiovasc Pharmacol Ther. 2011 Jun; 16(2):131-9. View in: PubMed

First direct comparison of the late sodium current blocker ranolazine to established antiarrhythmic agents in an ischemia/reperfusion model. J Cardiovasc Pharmacol Ther. 2011 Jun; 16(2):192-6. View in: PubMed

Cardiology patient page: cardiovascular implications of erectile dysfunction. Circulation. 2011 May 31; 123(21):e609-11. View in: PubMed

The combined administration of multiple soluble factors in the repair of chronically infarcted rat myocardium. J Cardiovasc Pharmacol. 2011 Mar; 57(3):282-6. View in: PubMed

Potential role of renin-angiotensin system blockade for preventing myocardial ischemia/reperfusion injury and remodeling after myocardial infarction. Postgrad Med. 2011 Mar; 123(2):49-55. View in: PubMed

Role of age, sex, and race on cardiac and total mortality associated with Super Bowl wins and losses. Clin Cardiol. 2011 Feb; 34(2):102-7. View in: PubMed

Clinical cardiology: physician update: erectile dysfunction and cardiovascular disease. Circulation. 2011 Jan 04; 123(1):98-101. View in: PubMed

Clinical cardiology: physician update: erectile dysfunction and cardiovascular disease. Circulation. 2011 Jan 4; 123(1):98-101. View in: PubMed

Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev. 2011 Jan; 16(1):13-21. View in: PubMed

Cardiovascular effects of cocaine. Circulation. 2010 Dec 14; 122(24):2558-69. View in: PubMed

Effects of zoledronate in the repair of chronically infarcted rat myocardium. J Cardiovasc Pharmacol. 2010 Dec; 56(6):604-9. View in: PubMed

Review of vascular closure devices. J Invasive Cardiol. 2010 Dec; 22(12):599-607. View in: PubMed

Sporting events affect spectators' cardiovascular mortality: it is not just a game. Am J Med. 2010 Nov; 123(11):972-7. View in: PubMed

No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy. J Interv Cardiol. 2010 Oct; 23(5):429-36. View in: PubMed

Blood supply of the graft after cellular cardiomyoplasty. Regen Med. 2010 Sep; 5(5):777-86. View in: PubMed

Influenza-related viral myocarditis. WMJ. 2010 Aug; 109(4):209-13. View in: PubMed

Comparison of automated oscillometric versus auscultatory blood pressure measurement. Am J Cardiol. 2010 Aug 01; 106(3):386-8. View in: PubMed

When and why do heart attacks occur? Cardiovascular triggers and their potential role. Hosp Pract (Minneap). 2010 Aug; 38(5):144-52. View in: PubMed

Stem cells for the treatment of heart failure. Curr Opin Mol Ther. 2010 Aug; 12(4):432-41. View in: PubMed

Comparison of automated oscillometric versus auscultatory blood pressure measurement. Am J Cardiol. 2010 Aug 1; 106(3):386-8. View in: PubMed

Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension. Circulation. 2010 Jul 06; 122(1):88-95. View in: PubMed

Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension. Circulation. 2010 Jul 6; 122(1):88-95. View in: PubMed

Improving regenerating potential of the heart after myocardial infarction: factor-based approach. Life Sci. 2010 Mar 27; 86(13-14):461-72. View in: PubMed

Cardioprotection with adenosine-regulating agent, GP531: effects on no-reflow, infarct size, and blood flow following ischemia/ reperfusion in the rabbit. J Cardiovasc Pharmacol Ther. 2010 Mar; 15(1):60-7. View in: PubMed

Ranolazine: an anti-anginal drug with further therapeutic potential. Expert Rev Cardiovasc Ther. 2010 Mar; 8(3):319-29. View in: PubMed

Experimental cell transplantation therapy in rat myocardial infarction model including nude rat preparation. Methods Mol Biol. 2010; 660:99-109. View in: PubMed

Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion model. Cardiovasc Ther. 2010; 28(1):30-7. View in: PubMed

ATL 313, A Selective A(2A) Adenosine Receptor Agonist, Reduces Myocardial Infarct Size in a Rat Ischemia/Reperfusion Model. Open Cardiovasc Med J. 2009 Nov 25; 3:166-72. View in: PubMed

Particulate air pollution and coronary heart disease. Curr Opin Cardiol. 2009 Nov; 24(6):604-9. View in: PubMed

Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2009 Nov; 297(5):H1923-9. View in: PubMed

Ranolazine as a cardioplegia additive improves recovery of diastolic function in isolated rat hearts. Circulation. 2009 Sep 15; 120(11 Suppl):S16-21. View in: PubMed

Critical role of nuclear calcium/calmodulin-dependent protein kinase IIdeltaB in cardiomyocyte survival in cardiomyopathy. J Biol Chem. 2009 Sep 11; 284(37):24857-68. View in: PubMed

Peripheral chronic total occlusions treated with subintimal angioplasty and a true lumen re-entry device. J Invasive Cardiol. 2009 Sep; 21(9):468-72. View in: PubMed

Intracoronary blood- or bone marrow-derived cell transplantation in patients with ischemic heart disease. Regen Med. 2009 Sep; 4(5):709-19. View in: PubMed

A salute to our founding editor-in-chief Bramah N. Singh, MD, DPhil, DSc, FRCP. J Cardiovasc Pharmacol Ther. 2009 Sep; 14(3):154-6. View in: PubMed

Phosphodiesterase 5 inhibitors: are they cardioprotective? Cardiovasc Res. Phosphodiesterase 5 inhibitors: are they cardioprotective? Cardiovasc Res. 2009 Jul 15; 83(2):204-12. View in: PubMed

Comparison of total and cardiovascular death rates in the same city during a losing versus winning super bowl championship. Am J Cardiol. 2009 Jun 15; 103(12):1647-50. View in: PubMed

The mechanism by which ischemic postconditioning reduces reperfusion arrhythmias in rats remains elusive. J Cardiovasc Pharmacol Ther. 2009 Jun; 14(2):99-103. View in: PubMed

Real-time intravascular shear stress in the rabbit abdominal aorta. IEEE Trans Biomed Eng. 2009 Jun; 56(6):1755-64. View in: PubMed

Ranolazine as an adjunct to cardioplegia: a potential new therapeutic application. J Cardiovasc Pharmacol Ther. 2009 Jun; 14(2):125-33. View in: PubMed

Ischemic preconditioning maintains cardioprotection in aging normotensive and spontaneously hypertensive rats. Exp Gerontol. 2009 May; 44(5):344-9. View in: PubMed

Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology. Regen Med. 2009 May; 4(3):387-95. View in: PubMed

Complication rate of diagnostic carotid angiography performed by interventional cardiologists. Catheter Cardiovasc Interv. 2009 Apr 01; 73(5):661-5. View in: PubMed

Complication rate of diagnostic carotid angiography performed by interventional cardiologists. Catheter Cardiovasc Interv. 2009 Apr 1; 73(5):661-5. View in: PubMed

Clinical application of remote ischemic preconditioning. Circulation. 2009 Feb 17; 119(6):776-8. View in: PubMed

Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy. J Am Coll Cardiol. 2009 Jan 27; 53(4):305-8. View in: PubMed

ATL 313, A Selective A(2A) Adenosine Receptor Agonist, Reduces Myocardial Infarct Size in a Rat Ischemia/Reperfusion Model. Open Cardiovasc Med J. 2009; 3:166-72. View in: PubMed

Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc Interv. 2008 Dec 01; 72(7):950-7. View in: PubMed

Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc Interv. 2008 Dec 1; 72(7):950-7. View in: PubMed

Blood pressure control with amlodipine add-on therapy in patients with hypertension and diabetes: results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial. Ann Pharmacother. 2008 Nov; 42(11):1552-62. View in: PubMed

Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: a quantitative assessment. Life Sci. 2008 Sep 26; 83(13-14):511-5. View in: PubMed

Direct and acute cardiotoxic effects of ultrafine air pollutants in spontaneously hypertensive rats and Wistar--Kyoto rats. J Cardiovasc Pharmacol Ther. 2008 Sep; 13(3):189-98. View in: PubMed

The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit. J Cardiovasc Pharmacol Ther. 2008 Sep; 13(3):226-32. View in: PubMed

Air pollution and cardiovascular injury epidemiology, toxicology, and mechanisms. J Am Coll Cardiol. 2008 Aug 26; 52(9):719-26. View in: PubMed

New insights into the open artery hypothesis. Circ Res. 2008 Jul 03; 103(1):1-3. View in: PubMed

New insights into the open artery hypothesis. Circ Res. 2008 Jul 3; 103(1):1-3. View in: PubMed

Ischemic postconditioning's benefit on reperfusion ventricular arrhythmias is maintained in the senescent heart. J Cardiovasc Pharmacol Ther. 2008 Jun; 13(2):141-8. View in: PubMed

Late sodium current inhibition as a new cardioprotective approach. J Mol Cell Cardiol. 2008 Jun; 44(6):954-67. View in: PubMed

Erectile dysfunction: the new harbinger for major adverse cardiac events in the diabetic patient. J Am Coll Cardiol. 2008 May 27; 51(21):2051-2. View in: PubMed

Glucose-insulin-potassium for acute myocardial infarction: continuing controversy over cardioprotection. Circulation. 2008 May 13; 117(19):2523-33. View in: PubMed

The cardiovascular safety of tadalafil. Expert Opin Drug Saf. 2008 Jan; 7(1):43-52. View in: PubMed

Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion. Am J Physiol Heart Circ Physiol. 2008 Jan; 294(1):H421-5. View in: PubMed

Preconditioning in humans. Heart Fail Rev. 2007 Dec; 12(3-4):201-6. View in: PubMed

Direct and acute cardiotoxicity of ultrafine particles in young adult and old rat hearts. Basic Res Cardiol. 2007 Nov; 102(6):467-75. View in: PubMed

Case studies: applying JNC-7 treatment guidelines. JAAPA. 2007 Nov; Suppl Hypertension:14-8. View in: PubMed

Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol. 2007 Oct; 43(4):504-16. View in: PubMed

Cocaine-induced acute myocardial infarction. Clin Med Res. 2007 Oct; 5(3):172-6. View in: PubMed

To drink or not to drink? That is the question. Circulation. 2007 Sep 11; 116(11):1306-17. View in: PubMed

Alterations in myostatin expression are associated with changes in cardiac left ventricular mass but not ejection fraction in the mouse. J Endocrinol. 2007 Jul; 194(1):63-76. View in: PubMed

Uncertainty on the use of aldosterone antagonists for primary therapy for sudden cardiac death in the setting of implanted devices. Circulation. 2007 Jun 12; 115(23):2983-9; discussion 2989. View in: PubMed

Postconditioning does not reduce myocardial infarct size in an in vivo regional ischemia rodent model. J Cardiovasc Pharmacol Ther. 2007 Jun; 12(2):153-63. View in: PubMed

Vardenafil: a selective inhibitor of phosphodiesterase-5 for the treatment of erectile dysfunction. Expert Opin Pharmacother. 2007 May; 8(7):965-74. View in: PubMed

Myocardial regeneration by human amniotic fluid stem cells: challenges to be overcome. J Mol Cell Cardiol. 2007 Apr; 42(4):730-2. View in: PubMed

Development of a spontaneously beating vein by cardiomyocyte transplantation in the wall of the inferior vena cava in a rat: a pilot study. J Vasc Surg. 2007 Apr; 45(4):817-20. View in: PubMed

ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. Circulation. 2007 Mar 27; 115(12):1656-95. View in: PubMed

ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. J Am Coll Cardiol. 2007 Mar 27; 49(12):1373-412. View in: PubMed

ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats. Task Force II: indirect and secondary cardiovascular effects of biological terrorism agents and diseases. Circulation. 2007 Mar 27; 115(12):1672-80. View in: PubMed

ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task Force II: indirect and secondary cardiovascular effects of biological terrorism agents and diseases. J Am Coll Cardiol. 2007 Mar 27; 49(12):1389-97. View in: PubMed

Stem cell therapy in the heart and vasculature. Methods Mol Med. 2007; 139:355-65. View in: PubMed

Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats. Regen Med. 2007 Jan; 2(1):63-8. View in: PubMed

Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit. J Cardiovasc Pharmacol Ther. 2006 Dec; 11(4):249-55. View in: PubMed

The Bolger conference on PDE-5 inhibition and HIV risk: implications for health policy and prevention. J Sex Med. 2006 Nov; 3(6):960-75; discussion 973-5. View in: PubMed

Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial. Eur Heart J. 2006 Oct; 27(20):2400-5. View in: PubMed

The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol. 2006 Sep; 101(5):359-72. View in: PubMed

Moving preconditioning from bench to bedside. J Am Coll Cardiol. 2006 Jul 4; 48(1):215-6. View in: PubMed

Moving preconditioning from bench to bedside. J Am Coll Cardiol. 2006 Jul 04; 48(1):215-6. View in: PubMed

Improved left ventricular function and reduced necrosis after myocardial ischemia/reperfusion in rabbits treated with ranolazine, an inhibitor of the late sodium channel. J Pharmacol Exp Ther. 2006 Jul; 318(1):418-23. View in: PubMed

Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing. Am J Cardiol. 2006 Jun 15; 97(12):1778-84. View in: PubMed

Ischemic preconditioning for the clinician. WMJ. 2006 Jun; 105(4):22-6. View in: PubMed

Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc Res. 2006 May 01; 70(2):297-307. View in: PubMed

Myocardial regeneration by embryonic stem cell transplantation: present and future trends. Expert Rev Cardiovasc Ther. 2006 May; 4(3):375-83. View in: PubMed

Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc Res. 2006 May 1; 70(2):297-307. View in: PubMed

Molecular aspects of ischemic heart disease: ischemia/reperfusion-induced genetic changes and potential applications of gene and RNA interference therapy. J Cardiovasc Pharmacol Ther. 2006 Mar; 11(1):17-30. View in: PubMed

Attempts to recruit stem cells for repair of acute myocardial infarction: a dose of reality. JAMA. 2006 Mar 1; 295(9):1058-60. View in: PubMed

Attempts to recruit stem cells for repair of acute myocardial infarction: a dose of reality. JAMA. 2006 Mar 01; 295(9):1058-60. View in: PubMed

Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics. J Cardiovasc Pharmacol. 2006 Mar; 47(3):493-9. View in: PubMed

Postconditioning markedly attenuates ventricular arrhythmias after ischemia-reperfusion. J Cardiovasc Pharmacol Ther. 2006 Mar; 11(1):55-63. View in: PubMed

In vivo and in vitro models to test the hypothesis of particle-induced effects on cardiac function and arrhythmias. Cardiovasc Toxicol. 2006; 6(1):69-78. View in: PubMed

Natural and unnatural triggers of myocardial infarction. Prog Cardiovasc Dis. 2006 Jan-Feb; 48(4):285-300. View in: PubMed

Cardiovascular effects of phosphodiesterase 5 inhibitors. Curr Pharm Des. 2006; 12(27):3485-94. View in: PubMed

Cardiac cells implanted within the outer aortic wall of rats generate measurable contractile force. Regen Med. 2006 Jan; 1(1):119-24. View in: PubMed

The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med. 2006 Jan; 3(1):28-36; discussion 36. View in: PubMed

Sexual function in hypertensive patients receiving treatment. Vasc Health Risk Manag. 2006; 2(4):447-55. View in: PubMed

Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions. Am J Cardiol. 2005 Dec 26; 96(12B):42M-46M. View in: PubMed

Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol. 2005 Dec 26; 96(12B):85M-93M. View in: PubMed

Stem cell transplantation for the treatment of myocardial infarction. Transpl Immunol. 2005 Dec; 15(2):91-7. View in: PubMed

The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease. Br J Clin Pharmacol. 2005 Nov; 60(5):459-68. View in: PubMed

Granulocyte colony-stimulating factor and stem cell factor improve contractile reserve of the infarcted left ventricle independent of restoring muscle mass. J Am Coll Cardiol. 2005 Nov 01; 46(9):1662-9. View in: PubMed

Granulocyte colony-stimulating factor and stem cell factor improve contractile reserve of the infarcted left ventricle independent of restoring muscle mass. J Am Coll Cardiol. 2005 Nov 1; 46(9):1662-9. View in: PubMed

Erectile dysfunction and cardiovascular risk factors. Urol Clin North Am. 2005 Nov; 32(4):397-402, v. View in: PubMed

Genetic contributors toward increased risk for ischemic heart disease. J Mol Cell Cardiol. 2005 Oct; 39(4):667-79. View in: PubMed

Commentaries on Jackson et al. "Successful withdrawal of oral long-acting nitrates to facilitate phosphodiesterase type 5 inhibitor use in stable coronary disease patients with erectile dysfunction". J Sex Med. 2005 Sep; 2(5):740-2; author reply 742. View in: PubMed

Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol. 2005 Aug 16; 46(4):714-9. View in: PubMed

The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval. J Am Coll Cardiol. 2005 Aug 16; 46(4):678-87. View in: PubMed

Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. Cardiovasc Res. 2005 Aug 01; 67(2):301-7. View in: PubMed

Administration of erythropoietin fails to improve long-term healing or cardiac function after myocardial infarction in the rat. J Cardiovasc Pharmacol. 2005 Aug; 46(2):211-5. View in: PubMed

Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. Cardiovasc Res. 2005 Aug 1; 67(2):301-7. View in: PubMed

Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol. 2005 Jul 15; 96(2):313-21. View in: PubMed

Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation. 2005 Jul 12; 112(2):214-23. View in: PubMed

A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol. 2005 Jun 7; 45(11):1775-80. View in: PubMed

A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol. 2005 Jun 07; 45(11):1775-80. View in: PubMed

Acetaminophen and myocardial stunning after transient ischemia in rabbit hearts. J Cardiovasc Pharmacol Ther. 2005 Jun; 10(2):121-9. View in: PubMed

Coronary No-reflow Phenomenon. Curr Treat Options Cardiovasc Med. 2005 May; 7(1):75-80. View in: PubMed

Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety. Expert Opin Drug Saf. 2005 May; 4(3):531-40. View in: PubMed

Task Force 9: drugs and performance-enhancing substances. J Am Coll Cardiol. 2005 Apr 19; 45(8):1368-9. View in: PubMed

Benefit of an exercise program before myocardial infarction. J Am Coll Cardiol. 2005 Mar 15; 45(6):939-40. View in: PubMed

Increased cardiovascular mortality associated with the turn of the millennium in Los Angeles County, California. J Epidemiol Community Health. 2005 Mar; 59(3):205-6. View in: PubMed

The "Merry Christmas Coronary" and "Happy New Year Heart Attack" phenomenon. Circulation. 2004 Dec 21; 110(25):3744-5. View in: PubMed

Ischemic preconditioning and preinfarction angina in the clinical arena. Nat Clin Pract Cardiovasc Med. 2004 Dec; 1(2):96-102. View in: PubMed

Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction. Circulation. 2004 Nov 09; 110(19):3149-55. View in: PubMed

Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction. Circulation. 2004 Nov 9; 110(19):3149-55. View in: PubMed

Stem cell therapy for the heart. Congest Heart Fail. 2004 Nov-Dec; 10(6):293-301. View in: PubMed

Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men. J Urol. 2004 Nov; 172(5 Pt 1):1935-40. View in: PubMed

Pharmacotherapy for erectile dysfunction. J Sex Med. 2004 Sep; 1(2):128-40. View in: PubMed

Microvascular alterations after temporary coronary artery occlusion: the no-reflow phenomenon. J Cardiovasc Pharmacol Ther. 2004 Sep; 9(3):163-72. View in: PubMed

Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events. J Sex Med. 2004 Sep; 1(2):161-7. View in: PubMed

New cellular and molecular approaches for the treatment of cardiac disease. Semin Nephrol. 2004 Sep; 24(5):437-40. View in: PubMed

Cardiac protection during acute myocardial infarction: where do we stand in 2004? J Am Coll Cardiol. Cardiac protection during acute myocardial infarction: where do we stand in 2004? J Am Coll Cardiol. 2004 Jul 21; 44(2):276-86. View in: PubMed

Gene therapy in congestive heart failure. Circulation. 2004 Jul 20; 110(3):242-3. View in: PubMed

Implantation of immature neonatal cardiac cells into the wall of the aorta in rats: a novel model for studying morphological and functional development of heart cells in an extracardiac environment. Circulation. 2004 Jul 20; 110(3):324-9. View in: PubMed

Metabolic mechanism by which mild regional hypothermia preserves ischemic tissue. J Cardiovasc Pharmacol Ther. 2004 Jun; 9(2):83-90. View in: PubMed

Effects of adenosine and verapamil on anatomic no-reflow in a rabbit model of coronary artery occlusion and reperfusion. J Cardiovasc Pharmacol. 2004 Apr; 43(4):580-8. View in: PubMed

Novel phosphodiesterase type 5 inhibitors: assessing hemodynamic effects and safety parameters. Clin Cardiol. 2004 Apr; 27(4 Suppl 1):I20-5. View in: PubMed

Acetaminophen and experimental acute myocardial infarction. Cardiovasc Drugs Ther. 2004 Mar; 18(2):121-5. View in: PubMed

Assessment of cardiovascular risk in patients with erectile dysfunction: focus on the diabetic patient. Endocrine. 2004 Mar-Apr; 23(2-3):125-9. View in: PubMed

Relationship between cyclooxygenase-2 inhibition and thrombogenesis. J Cardiovasc Pharmacol Ther. 2004 Mar; 9(1):51-9. View in: PubMed

Glycoprotein IIb/IIIa inhibitors and no-reflow. J Am Coll Cardiol. 2004 Jan 21; 43(2):284-6. View in: PubMed

Erectile dysfunction in the cardiac patient. Compr Ther. 2004; 30(1):50-4. View in: PubMed

Age-related changes of cardiac gene expression following myocardial ischemia/reperfusion. Arch Biochem Biophys. 2003 Dec 15; 420(2):268-78. View in: PubMed

No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation. 2003 Dec 09; 108(23):2911-7. View in: PubMed

No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation. 2003 Dec 9; 108(23):2911-7. View in: PubMed

Mechanisms of myocardial ischemic preconditioning are age related: PKC-epsilon does not play a requisite role in old rabbits. J Appl Physiol. 2003 Dec; 95(6):2563-9. View in: PubMed

Erectile dysfunction in the cardiac patient. Curr Urol Rep. 2003 Dec; 4(6):466-71. View in: PubMed

Effects of acetaminophen on myocardial infarct size in rats. J Cardiovasc Pharmacol Ther. 2003 Dec; 8(4):277-84. View in: PubMed

Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol. 2003 Nov 19; 42(10):1855-60. View in: PubMed

Roundtable discussion: tadalafil study group. Am J Cardiol. 2003 Nov 6; 92(9A):58M-65M. View in: PubMed

Cardiovascular effects of tadalafil in patients on common antihypertensive therapies. Am J Cardiol. 2003 Nov 6; 92(9A):47M-57M. View in: PubMed

Cardiovascular effects of tadalafil. Am J Cardiol. 2003 Nov 6; 92(9A):37M-46M. View in: PubMed

Cardiovascular effects of tadalafil. Am J Cardiol. 2003 Nov 06; 92(9A):37M-46M. View in: PubMed

Introduction: Erectile dysfunction and cardiovascular risk factors. Am J Cardiol. 2003 Nov 06; 92(9A):1-2. View in: PubMed

Sildenafil in patients with cardiovascular disease. Am J Cardiol. 2003 Nov 06; 92(9A):26M-36M. View in: PubMed

Introduction: Erectile dysfunction and cardiovascular risk factors. Am J Cardiol. 2003 Nov 6; 92(9A):1-2. View in: PubMed

Sildenafil in patients with cardiovascular disease. Am J Cardiol. 2003 Nov 6; 92(9A):26M-36M. View in: PubMed

Roundtable discussion: tadalafil study group. Am J Cardiol. 2003 Nov 06; 92(9A):58M-65M. View in: PubMed

Cardiovascular effects of tadalafil in patients on common antihypertensive therapies. Am J Cardiol. 2003 Nov 06; 92(9A):47M-57M. View in: PubMed

New therapy update. Inspra (eplerenone tablets). Congest Heart Fail. 2003 Nov-Dec; 9(6):341-2. View in: PubMed

Cardiovascular mortality in New York City after September 11, 2001. Am J Cardiol. 2003 Oct 01; 92(7):857-61. View in: PubMed

Cardiovascular mortality in New York City after September 11, 2001. Am J Cardiol. 2003 Oct 1; 92(7):857-61. View in: PubMed

Hypothermia during reperfusion limits 'no-reflow' injury in a rabbit model of acute myocardial infarction. Cardiovasc Res. 2003 Sep 01; 59(3):715-22. View in: PubMed

Transthoracic echocardiography in rats. Evalution of commonly used indices of left ventricular dimensions, contractile performance, and hypertrophy in a genetic model of hypertrophic heart failure (SHHF-Mcc-facp-Rats) in comparison with Wistar rats during aging. Basic Res Cardiol. 2003 Sep; 98(5):275-84. View in: PubMed

Coronary no-flow and ventricular tachycardia associated with habitual marijuana use. Ann Emerg Med. 2003 Sep; 42(3):365-9. View in: PubMed

Hypothermia during reperfusion limits 'no-reflow' injury in a rabbit model of acute myocardial infarction. Cardiovasc Res. 2003 Sep 1; 59(3):715-22. View in: PubMed

Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003 Aug 19; 108(7):863-8. View in: PubMed

Effects of sildenafil on myocardial infarct size, microvascular function, and acute ischemic left ventricular dilation. Cardiovasc Res. 2003 Aug 1; 59(2):441-9. View in: PubMed

Effects of sildenafil on myocardial infarct size, microvascular function, and acute ischemic left ventricular dilation. Cardiovasc Res. 2003 Aug 01; 59(2):441-9. View in: PubMed

Brief episode of ischemia activates protective genetic program in rat heart: a gene chip study. Cardiovasc Res. 2003 Aug 01; 59(2):450-9. View in: PubMed

Third International Conference on the Management of Erectile Dysfunction: Linking Pathophysiology and Therapeutic Response. J Urol. 2003 Aug; 170(2 Pt 2):S3-5. View in: PubMed

Erectile dysfunction in the cardiac patient: how common and should we treat? J Urol. Erectile dysfunction in the cardiac patient: how common and should we treat? J Urol. 2003 Aug; 170(2 Pt 2):S46-50; discussion S50. View in: PubMed

Brief episode of ischemia activates protective genetic program in rat heart: a gene chip study. Cardiovasc Res. 2003 Aug 1; 59(2):450-9. View in: PubMed

Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease. Circulation. 2003 Jul 15; 108(2):239-44. View in: PubMed

Reprogramming cells for transplantation. Heart Fail Rev. 2003 Jul; 8(3):285-92. View in: PubMed

Hospital admissions for cardiac events in New York City after September 11, 2001. Am J Cardiol. 2003 Jul 01; 92(1):61-3. View in: PubMed

Hospital admissions for cardiac events in New York City after September 11, 2001. Am J Cardiol. 2003 Jul 1; 92(1):61-3. View in: PubMed

Cardiomyocyte transplantation into the failing heart-new therapeutic approach for heart failure? Heart Fail Rev. Cardiomyocyte transplantation into the failing heart-new therapeutic approach for heart failure? Heart Fail Rev. 2003 Jul; 8(3):201-11. View in: PubMed

Gene expression profiling--a new approach in the study of myocardial ischemia. Cardiovasc Pathol. 2003 Jul-Aug; 12(4):180-5. View in: PubMed

Long-term outcome of fetal cell transplantation on postinfarction ventricular remodeling and function. J Mol Cell Cardiol. 2003 Jun; 35(6):661-70. View in: PubMed

Transplantation of neonatal cardiomyocytes after permanent coronary artery occlusion increases regional blood flow of infarcted myocardium. J Mol Cell Cardiol. 2003 Jun; 35(6):607-13. View in: PubMed

Development of abnormal tissue architecture in transplanted neonatal rat myocytes. Ann Thorac Surg. 2003 May; 75(5):1450-6. View in: PubMed

Cellular cardiomyoplasty--cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? Cardiovasc Res. Cellular cardiomyoplasty--cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? Cardiovasc Res. 2003 May 01; 58(2):358-68. View in: PubMed

Cellular cardiomyoplasty--cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? Cardiovasc Res. Cellular cardiomyoplasty--cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? Cardiovasc Res. 2003 May 1; 58(2):358-68. View in: PubMed

Is microvascular protection by cariporide and ischemic preconditioning causally linked to myocardial salvage? Am J Physiol Heart Circ Physiol. Is microvascular protection by cariporide and ischemic preconditioning causally linked to myocardial salvage? Am J Physiol Heart Circ Physiol. 2003 Apr; 284(4):H1134-41. View in: PubMed

Cocaine and the heart. N Engl J Med. 2003 Feb 6; 348(6):487-8. View in: PubMed

Cocaine and the heart. N Engl J Med. 2003 Feb 06; 348(6):487-8. View in: PubMed

The effects of amlodipine compared to losartan in patients with mild to moderately severe hypertension. J Clin Hypertens (Greenwich). 2003 Jan-Feb; 5(1):17-23. View in: PubMed

Cellular cardiomyoplasty of cardiac fibroblasts by adenoviral delivery of MyoD ex vivo: an unlimited source of cells for myocardial repair. Circulation. 2002 Sep 24; 106(12 Suppl 1):I125-30. View in: PubMed

Erectile dysfunction and atherosclerosis. Curr Atheroscler Rep. 2002 Sep; 4(5):397-401. View in: PubMed

A 4-year update on the safety of sildenafil citrate (Viagra). Urology. 2002 Sep; 60(2 Suppl 2):67-90. View in: PubMed

Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol. 2002 Sep; 283(3):H1099-107. View in: PubMed

Ischemic preconditioning: a plea for rationally targeted clinical trials. Cardiovasc Res. 2002 Aug 15; 55(3):526-33. View in: PubMed

Health care clinicians in sexual health medicine: focus on erectile dysfunction. Urol Nurs. 2002 Aug; 22(4):217-31; quiz 232. View in: PubMed

Cellular cardiomyoplasty--a novel approach to treat heart disease. Congest Heart Fail. 2002 Jul-Aug; 8(4):220-7. View in: PubMed

Comparison of acute myocardial infarct size in patients > or =65 years versus < 65 years in the prethrombolytic period versus the thrombolytic period. Am J Cardiol. 2002 Jun 01; 89(11):1291-3. View in: PubMed

Comparison of acute myocardial infarct size in patients > or =65 years versus < 65 years in the prethrombolytic period versus the thrombolytic period. Am J Cardiol. 2002 Jun 1; 89(11):1291-3. View in: PubMed

Elevated body temperature during myocardial ischemia/reperfusion exacerbates necrosis and worsens no-reflow. Coron Artery Dis. 2002 May; 13(3):177-81. View in: PubMed

The gap junction uncoupler heptanol abrogates infarct size reduction with preconditioning in mouse hearts. Cardiovasc Pathol. 2002 May-Jun; 11(3):158-65. View in: PubMed

Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation. 2002 Apr 09; 105(14):1720-6. View in: PubMed

Rebuilding a damaged heart: long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation. 2002 Apr 9; 105(14):1720-6. View in: PubMed

Gene activity changes in ischemically preconditioned rabbit heart gene: discovery array study. Heart Dis. 2002 Mar-Apr; 4(2):63-9. View in: PubMed

Renovascular hypertension: problems in evaluation and management. Chest. 2002 Mar; 121(3):964-8. View in: PubMed

No-reflow phenomenon. Circulation. 2002 Feb 05; 105(5):656-62. View in: PubMed

No-reflow phenomenon. Circulation. 2002 Feb 5; 105(5):656-62. View in: PubMed

Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2002 Feb; 282(2):H766-72. View in: PubMed

Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J Mol Cell Cardiol. 2002 Feb; 34(2):107-16. View in: PubMed

The "no-reflow" phenomenon: basic science and clinical correlates. Heart. 2002 Feb; 87(2):162-8. View in: PubMed

Myocardial infarction temporally related to ephedra--a possible role for the coronary microcirculation. WMJ. 2002; 101(7):64-6. View in: PubMed

Hypertension as a Risk for Erectile Dysfunction: Implications for Sildenafil Use. J Clin Hypertens (Greenwich). 2000 Jan; 2(1):33-36. View in: PubMed

When and why do heart attacks occur? Cardiovascular triggers and their potential role. Hosp Pract (1995). 2010; 38(3):144-52. View in: PubMed

Protecting the heart from ischemia: an update on ischemic and pharmacologic conditioning. Hosp Pract (1995). 2011 Aug; 39(3):35-43. View in: PubMed

Mechanisms of myocardial ischemic preconditioning are age related: PKC-epsilon does not play a requisite role in old rabbits. J Appl Physiol (1985). 2003 Dec; 95(6):2563-9. View in: PubMed

Powered bySC CTSI